ClubsMakklerPROMarketsEconomic CalendarEarnings CalendarNewsMakklerAIFamous Investors
ENTRDE
Log InGet Started Free
OverviewStocksCryptoCurrenciesCommoditiesETFsOptionsEconomic CalendarEarnings CalendarGuru PortfoliosMy watchlist

Makkler App

Faster and clearer

Install
Overview/Stocks/AZR

Azora Therapeutics, Inc. AZR

NASDAQHealth TechnologyUnited States
$4.00+0.29 (+7.82%)

Market closed· Nov 6, 2026, 9:00 PM UTC· USD · Data may be delayed

Day's range
3.764.00
52-week range
1.318.75

Financial health

– / 5

Analyst view · 5 firms

Buy5 buy · 0 hold · 0 sell

Avg. target $10.75 (+168.8%)

OverviewFinancialsAnalysisEarningsTechnicalsHistorical dataNews

Prices may be delayed and are for informational purposes only - not investment advice.

Overview
Stocks
Crypto
Currencies
Commodities
ETFs
Options
Economic Calendar
Earnings Calendar
Guru Portfolios
My watchlist
See with MakklerPRO
Details
Clubs
MakklerPRO
Markets
Economic Calendar
Earnings Calendar
News
MakklerAI
Famous Investors
Log In
Get Started Free

The portfolio-sharing platform connecting finance analysts with an audience that wants to learn.

Theme
Platform
ClubsMarketsMarkets NewsMakklerPROMakkler TokenHow It WorksBecome an Analyst
Compare
Makkler vs. eToroMakkler vs. SkoolMakkler vs. YouTube
Company
About UsContact
Legal
Terms of ServicePrivacy PolicyData Protection NoticeRisk DisclosurePayment Policy

© 2026 Makkler, LLC. All rights reserved. Content on this platform does not constitute investment advice.

ENTRDE
-15.79% · 6M
Full-screen chart
Nov 6, 2026Open $4.00High $4.00Low $4.00Close $4.00
$4.75$3.15
Oct 29, 2026Nov 6, 2026
USD · 15 min delayedTradingView Lightweight Charts

Key statistics

Profitability and valuation from the filed statements

All financials

Price and trading

Previous close
$3.71
Day range
$3.76 – $4.00
Volume
78.20K
Avg. volume (1Y)
160.04K
Beta
1.64
Volatility (1 year)
112.0%

Valuation

Market cap
$10.50M
Dividend yield (annualized)
0.00%
Makkler Fair Value

Profitability · trailing 12 months

Revenue
$0
Net Income
-$57.80M
EPS (TTM)
$-86.45

Returns

Total return, dividends included.

1 week
+2.8%
1 month
+0.3%
3 months
+0.5%
6 months
+181.7%
Year to date
-33.3%
1 year
-51.5%

AZR with MakklerAIPRO

Answers from price, statements, peer and news data. Not investment advice.

MakklerAI Q&A is open to MakklerPRO members. Upgrade to MakklerPRO

AZR news

  • Nov 5, 2026
    Azora Therapeutics Appoints Board of Directors with Extensive Drug Development and Inflammatory Bowel Disease ExpertiseYahoo Finance
  • Oct 29, 2026
    Adial Pharmaceuticals, Inc. Announces Name Change to Azora Therapeutics, Inc. and New Executive Appointments on October 28, 2026Fintel
  • Aug 17, 2026
    Adial Posts Q2 2026 Results; Acquisition Of Azora Therapeutics Shifts Focus To UC; Stock DownRTTNews
  • Jun 23, 2026
    Azarga Metals Shareholders Approve All Resolutions at Annual General and Special Meeting

Next report

Nov 18, 2026

in 11 days ·

Technical view

Mixed
20D avg.3.8550D avg.4.50200D avg.3.18

Where the price sits against its 50- and 200-day moving averages.

Company profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Country
United States
Exchange
NASDAQ
IPO date
2018-07-27
Shares outstanding
2.63M
Yahoo Finance
  • Jun 12, 2026
    Adial Acquires Azora With $64 Mln Private Placement; To Advance AT177 For Ulcerative ColitisRTTNews
    • Employees
    6
    ISIN
    US0548001074
    Beta
    1.64
    Website
    www.adial.com

    Similar companies

    • CUPRCuprina Holdings (Cayman) Limited Class A—
    • AEONAEON Biopharma, Inc. Class A—
    • RKTORocket One Inc.—
    • HINDVyome Holdings, Inc.—
    Peer comparison
    Unlock with MakklerPRO
    All news
    Past reports
    Details